Based on data from parallel traders in Denmark, we find that the total savings from parallel import of pharmaceuticals in 2018 amounted to DKK 610 million, or 3% of the total expenditure on pharmaceuticals in Denmark.

Parallel import of pharmaceuticals has taken place in Denmark and the rest of the EU since the 1970s. In 2018, parallel imports accounted for 14% of turnover in the Danish market for medicinal products.

Learn more about the study
For further information, please contact Søren Brenøe